(Q36615197)

15 August 2017

Boceprevir plus peginterferon/ribavirin for treatment of chronic hepatitis C in Russia (English)

1 reference

15 August 2017

1 reference

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26962399%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Igor Nikitin

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26962399%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Vladimir P. Chulanov

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26962399%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

4

Pavel Ogurtsov

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26962399%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

author name string

Ekaterina Lukyanova

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26962399%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Jianmin Long

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26962399%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Janice Wahl

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26962399%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Frans A Helmond

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26962399%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

P08160 Trial Investigators

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26962399%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

publication date

1 February 2016

1 reference

World Journal of Hepatology

15 August 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26962399%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26962399%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26962399%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

page(s)

331-339

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26962399%20AND%20SRC:MED&resulttype=core&format=json

Interferon-Free Regimens for Chronic Hepatitis C: Barriers Due to Treatment Candidacy and Insurance Coverage

1 June 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4766261

Revolution in hepatitis C antiviral therapy

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4766261

New hepatitis C therapies: the toolbox, strategies, and challenges

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4766261

Boceprevir for previously treated chronic HCV genotype 1 infection

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4766261

Boceprevir for untreated chronic HCV genotype 1 infection

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4766261

Evolving epidemiology of hepatitis C virus

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4766261

SCH 503034, a mechanism-based inhibitor of hepatitis C virus NS3 protease, suppresses polyprotein maturation and enhances the antiviral activity of alpha interferon in replicon cells

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4766261

Efficacy of 24 weeks treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C infected with genotype 1 and low pretreatment viremia

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4766261

EASL Clinical Practice Guidelines: management of hepatitis C virus infection

20 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26962399

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

World Gastroenterology Organisation global guidelines: diagnosis, management and prevention of hepatitis C April 2013

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26962399

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.4254/WJH.V8.I6.331

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26962399%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26962399%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

PubMed publication ID

26962399

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26962399%20AND%20SRC:MED&resulttype=core&format=json